Suppr超能文献

鞘内注射曲马多预防蛛网膜下腔阻滞后麻醉后寒战:两种不同剂量(10毫克和20毫克)的前瞻性随机安慰剂对照比较

Intrathecal Tramadol for Prevention of Postanesthesia Shivering after Subarachnoid Block: A Prospective Randomized Placebo-Controlled Comparison of Two Different Doses (10 and 20 mg).

作者信息

Gupta Priyanka, Gupta Mayank

机构信息

Department of Anaesthesia, ICU and Pain, Shri Mahant Indiresh Hospital, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India.

出版信息

Anesth Essays Res. 2018 Apr-Jun;12(2):495-500. doi: 10.4103/aer.AER_75_18.

Abstract

BACKGROUND

Shivering is a common and distressing complication following subarachnoid block (SAB). Literature comparing the antishivering efficacy of different doses of intrathecal (IT) tramadol is lacking.

AIMS

This prospective randomized controlled study was undertaken to evaluate and compare the antishivering efficacy of IT tramadol 10 and 20 mg.

METHODS

Ninety adult patients undergoing lower limb orthopedic surgeries under SAB were randomized into three groups ( = 30) to receive IL 0.5% hyperbaric bupivacaine 3 ml with tramadol 0 mg (Group C), 10 mg (Group T10), or 20 mg (Group T20) in normal saline. Shivering was assessed using a 5-point intensity scoring system intraoperatively and up to 4-h postoperatively. The onset and duration of sensory and motor block, duration of analgesia, and adverse effects were assessed.

STATISTICAL ANALYSIS USED

Analysis of variance and Pearson Chi-square test were used for statistical analysis.

RESULTS

The incidence and intensity of shivering were significantly reduced in Group T10 versus C (incidence, = 0.007; intensity, = 0.002) and T20 versus C (incidence, < 0.001; intensity, < 0.001) but comparable among groups T10 and T20 (incidence, = 0.133; intensity, = 0.142). There was a significant dose-dependent prolongation of duration of sensory block (121, 137, and 150.5 min; = 0.001), motor block (242.83, 298.5, and 344 min; < 0.001), and analgesia (289.17, 357, and 404.67 min; < 0.001) with escalating doses of IT tramadol, respectively. All the groups were comparable with respect to hemodynamic variables, core temperature, and adverse effects.

CONCLUSION

The addition of tramadol 10 or 20 mg IT to 0.5% hyperbaric bupivacaine for SAB is associated with significant reduction in the incidence and intensity of postanesthesia shivering and prolongation of the duration of postoperative analgesia. Tramadol 20 mg IT compared to 10 mg IT significantly prolonged the duration of postoperative analgesia but failed to demonstrate any significant attenuation of postanesthesia shivering.

摘要

背景

寒战是蛛网膜下腔阻滞(SAB)后常见且令人困扰的并发症。目前缺乏比较不同剂量鞘内注射(IT)曲马多抗寒战疗效的文献。

目的

本前瞻性随机对照研究旨在评估和比较IT曲马多10mg和20mg的抗寒战疗效。

方法

90例接受SAB下行下肢骨科手术的成年患者被随机分为三组(每组n = 30),分别接受含0mg曲马多(C组)、10mg曲马多(T10组)或20mg曲马多(T20组)的0.5%高压布比卡因3ml生理盐水溶液。术中及术后4小时内使用5分强度评分系统评估寒战情况。评估感觉和运动阻滞的起效时间和持续时间、镇痛持续时间及不良反应。

所用统计分析方法

采用方差分析和Pearson卡方检验进行统计分析。

结果

与C组相比,T10组寒战的发生率和强度显著降低(发生率,P = 0.007;强度,P = 0.002),T20组与C组相比亦显著降低(发生率,P < 0.001;强度,P < 0.001),但T10组和T20组之间相当(发生率,P = 0.133;强度,P = 0.142)。随着IT曲马多剂量增加,感觉阻滞持续时间(121、137和150.5分钟;P = 0.001)、运动阻滞持续时间(242.83、298.5和344分钟;P < 0.001)和镇痛持续时间(289.17、357和404.67分钟;P < 0.001)均有显著的剂量依赖性延长。所有组在血流动力学变量、核心体温及不良反应方面相当。

结论

SAB时,在0.5%高压布比卡因中加入10mg或20mg IT曲马多可显著降低麻醉后寒战的发生率和强度,并延长术后镇痛时间。与10mg IT曲马多相比,20mg IT曲马多显著延长了术后镇痛时间,但未显示出对麻醉后寒战有任何显著的减轻作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ce/6020564/c0ea31178034/AER-12-495-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验